Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 45 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 19 | 811−12%/yr | −12%/yr | 2.10.6× | 24% | 720 in 2030−2%/yr |
| Lumbar fusion | 14 | 679−5.9%/yr | −5.9%/yr | 1.80.5× | 0% | 520 in 2030−4.5%/yr |
| Kyphoplasty & vertebroplasty | 7 | 578−8.4%/yr | −8.4%/yr | 1.50.9× | 34% | 660 in 2030+2.3%/yr |
| Cervical fusion & disc arthroplasty | 13 | 506−7.3%/yr | −7.3%/yr | 1.30.8× | 24% | 500 in 2030−0.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 171 | 53,180+8.6%/yr | +8.6%/yr | 136.31.2× | 38% | 92,200 in 2030+9.6%/yr |
| Skin substitutes & wound grafts | 39 | 8,487+28%/yr | +28%/yr | 15.31.4× | 68% | 14,900 in 2030+9.8%/yr |
| Bone graft & orthobiologics | 5 | 119−17%/yr | −17%/yr | 0.30.4× | 11% | 90 in 2030−4.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 50 | 4,876+2%/yr | +2%/yr | 12.50.9× | 86% | 7,510 in 2030+7.5%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 13 | 445+2.3%/yr | +2.3%/yr | 1.10.8× | 76% | 590 in 2030+4.7%/yr |
| Spinal cord & DRG stimulation | 10 | 380−3%/yr | −3%/yr | 1.01.0× | 72% | 490 in 2030+4.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 27 | 2,361−7.9%/yr | −7.9%/yr | 6.11.0× | 73% | 2,320 in 2030−0.3%/yr |
| Dialysis access | 17 | 1,861−18%/yr | −18%/yr | 5.10.9× | 36% | 1,780 in 2030−0.7%/yr |
| Superficial venous ablation | 14 | 1,432−1.3%/yr | −1.3%/yr | 3.70.6× | 88% | 1,870 in 2030+4.6%/yr |
| Thrombectomy, IVC filters & venous stents | 6 | 554+0.1%/yr | +0.1%/yr | 1.50.9× | 4% | 570 in 2030+0.6%/yr |
| Carotid revascularization | 11 | 448−8.8%/yr | −8.8%/yr | 1.20.9× | 0% | 340 in 2030−4.7%/yr |
| Aortic endografts (EVAR/TEVAR) | 2 | 121−7.9%/yr | −7.9%/yr | 0.30.7× | 0% | 130 in 2030+1.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 23 | 2,013−6.1%/yr | −6.1%/yr | 5.60.9× | 2% | 2,210 in 2030+1.6%/yr |
| Cholecystectomy & appendectomy | 52 | 1,864−9.9%/yr | −9.9%/yr | 5.11.1× | 7% | 1,780 in 2030−0.8%/yr |
| Colorectal resection | 5 | 704−8.2%/yr | −8.2%/yr | 1.91.1× | 0% | 680 in 2030−0.7%/yr |
| Antireflux & hiatal hernia surgery | 3 | 297−1.9%/yr | −1.9%/yr | 0.81.0× | 0% | 300 in 2030+0.1%/yr |
| Breast reconstruction | 0 | 123−12%/yr | −12%/yr | 0.30.7× | 58% | 90 in 2030−4.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 43 | 2,629−1.4%/yr | −1.4%/yr | 7.11.4× | 30% | 2,760 in 2030+0.8%/yr |
| BPH procedures | 29 | 2,122−13%/yr | −13%/yr | 5.61.1× | 48% | 1,630 in 2030−4.3%/yr |
| Incontinence, prolapse & sacral neuromodulation | 14 | 901−6.8%/yr | −6.8%/yr | 2.40.9× | 45% | 1,040 in 2030+2.4%/yr |
| Hysterectomy, hysteroscopy & ablation | 8 | 600−6.8%/yr | −6.8%/yr | 1.70.6× | 9% | 590 in 2030−0.3%/yr |
| Prostatectomy & nephrectomy | 9 | 389−6.1%/yr | −6.1%/yr | 1.10.9× | 0% | 330 in 2030−2.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 20 | 1,659−6.5%/yr | −6.5%/yr | 4.50.9× | 91% | 1,580 in 2030−0.9%/yr |
| Sleep apnea & airway implants | 4 | 204+118%/yr | +118%/yr | 0.52.3× | 0% | 280 in 2030+5.3%/yr |
| Ear tubes & middle ear surgery | 1 | 165−6.9%/yr | −6.9%/yr | 0.41.3× | 49% | 120 in 2030−4.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 36 | 1,779−6.5%/yr | −6.5%/yr | 5.00.7× | 22% | 1,620 in 2030−1.5%/yr |
| Tumor & fibroid embolization | 6 | 194+19%/yr | +19%/yr | 0.50.9× | 36% | 380 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 54 | 11,559+40%/yr | +40%/yr | 30.41.1× | 85% | 20,500 in 2030+10%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 27 | 1,618−8.6%/yr | −8.6%/yr | 4.50.8× | 6% | 1,500 in 2030−1.3%/yr |
| LAA occlusion & loop recorders | 37 | 1,533+9.3%/yr | +9.3%/yr | 3.61.0× | 28% | 2,480 in 2030+8.3%/yr |
| EP ablation | 10 | 693−0.9%/yr | −0.9%/yr | 1.60.4× | 0% | 1,160 in 2030+9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 69 | 2,933−9.1%/yr | −9.1%/yr | 6.61.1× | 6% | 2,780 in 2030−0.9%/yr |
| Structural heart (TAVR, TEER) | 30 | 446+8%/yr | +8%/yr | 1.00.7× | 0% | 590 in 2030+4.9%/yr |
| Mechanical circulatory support | 0 | 161−10%/yr | −10%/yr | 0.40.8× | 0% | 180 in 2030+1.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Aneurysm & intracranial embolization | 4 | 119+13%/yr | +13%/yr | 0.30.7× | 0% | 110 in 2030−1.2%/yr |
| Stroke thrombectomy | 3 | 111−3.4%/yr | −3.4%/yr | 0.30.7× | 0% | 170 in 2030+7.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 74 | 21,062−3.1%/yr | −3.1%/yr | 55.30.9× | 96% | 21,400 in 2030+0.3%/yr |
| Vitreoretinal surgery | 11 | 1,000−1.3%/yr | −1.3%/yr | 2.71.0× | 72% | 1,010 in 2030+0.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 126 | 39,544−7.4%/yr | −7.4%/yr | 108.90.9× | 60% | 37,000 in 2030−1.1%/yr |
| Bronchoscopy & lung nodule | 20 | 1,240+1.2%/yr | +1.2%/yr | 3.31.0× | 0% | 1,510 in 2030+3.4%/yr |
| ERCP & endoscopic ultrasound | 11 | 634−4%/yr | −4%/yr | 1.70.5× | 5% | 710 in 2030+1.9%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.